Assignee
TISSUETECH INC
US·27 granted patents·19 pending applications·298 citations·filing 2003–2022
Top patents by PatentIndex Score
46 records- 0196US9198939B2Purified amniotic membrane compositions and methods of useTISSUETECH INC·Filed 2013·Granted Dec 1, 2015·18 cites·14 claims
- 0296US9161955B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·19 cites·12 claims
- 0395US10632155B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2018·Granted Apr 28, 2020·5 cites·14 claims
- 0495US9956252B2Purified amniotic membrane compositions and methods of useTISSUETECH INC·Filed 2015·Granted May 1, 2018·10 cites·20 claims
- 0595US9161956B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·16 cites·12 claims
- 0694US9750771B2Amniotic membrane preparations and purified compositions and anti-inflammation methodsTISSUETECH INC·Filed 2015·Granted Sep 5, 2017·8 cites·15 claims
- 0794US9724370B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2015·Granted Aug 8, 2017·8 cites·11 claims
- 0894US9161954B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTISSUETECH INC·Filed 2013·Granted Oct 20, 2015·18 cites·12 claims
- 0993US9682160B2Methods of sterilizing fetal support tissuesTISSUETECH INC·Filed 2015·Granted Jun 20, 2017·8 cites·20 claims
- 1092US10272119B2Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibitionTISSUETECH INC·Filed 2017·Granted Apr 30, 2019·5 cites·13 claims
- 1192US9808491B2Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereofTISSUETECH INC·Filed 2015·Granted Nov 7, 2017·11 cites·31 claims
- 1292US9750772B2Amniotic membrane preparations and purified compositions and anti-angiogenesis treatmentTISSUETECH INC·Filed 2015·Granted Sep 5, 2017·9 cites·13 claims
- 1392US9675733B2Methods of modulating bone remodelingTISSUETECH INC·Filed 2016·Granted Jun 13, 2017·5 cites·10 claims
- 1491US7824671B2Retinal pigment epithelial cell cultures on amniotic membrane and transplantationTISSUETECH INC·Filed 2003·Granted Nov 2, 2010·50 cites·15 claims
- 1589US10342831B2Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cellsTISSUETECH INC·Filed 2016·Granted Jul 9, 2019·3 cites·10 claims
- 1686US8940294B2Methods of isolating and culturing stem cellsTISSUETECH INC·Filed 2013·Granted Jan 27, 2015·5 cites·24 claims
- 1785US10717763B2Compositions containing HC-HA/PTX3 complexes and methods of use thereofTISSUETECH INC·Filed 2019·Granted Jul 21, 2020·2 cites·20 claims
- 1885US10426731B2Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereofTISSUETECH INC·Filed 2017·Granted Oct 1, 2019·6 cites·27 claims
- 1985US8865232B2Method for treating ocular DemodexTISSUETECH INC·Filed 2013·Granted Oct 21, 2014·3 cites·20 claims
- 2084US11518782B2Compositions containing HC-HA/PTX3 complexes and methods of use thereofTISSUETECH INC·Filed 2020·Granted Dec 6, 2022·1 cites·11 claims
- 2184US10253065B2Compositions containing HC-HA/PTX3 complexes and methods of use thereofTISSUETECH INC·Filed 2016·Granted Apr 9, 2019·4 cites·24 claims
- 2282US11318169B2Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cellsTISSUETECH INC·Filed 2019·Granted May 3, 2022·2 cites·9 claims
- 2381US11590265B2Apparatuses and methods for treating ophthalmic diseases and disordersTISSUETECH INC·Filed 2019·Granted Feb 28, 2023·3 cites·16 claims
- 2481US11116800B2Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereofTISSUETECH INC·Filed 2017·Granted Sep 14, 2021·2 cites·18 claims
- 2581US10040821B2Compositions containing HC-HA/PTX3 complexes and methods of use thereofTISSUETECH INC·Filed 2013·Granted Aug 7, 2018·4 cites·24 claims
- 2674US7494802B2Amniotic membrane covering for a tissue surface and devices facilitating fastening of membranesTISSUETECH INC·Filed 2003·Granted Feb 24, 2009·72 cites·109 claims
- 2772US2022175849A1Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cellsTISSUETECH INC·Filed 2022·Application pending·0 cites
- 2871US8865233B2Compositions and methods for treating Demodex infestationsTISSUETECH INC·Filed 2013·Granted Oct 21, 2014·1 cites·16 claims
- 2964US2009214676A1Method for treating ocular demodexTISSUETECH INC·Filed 2006·Application pending·0 cites
- 3061US2013344163A1Umbilical cord productsTISSUETECH INC·Filed 2013·Application pending·0 cites
- 3159US2016303171A1Umbilical cord amniotic membrane productsTISSUETECH INC·Filed 2016·Application pending·0 cites
- 3259US2016324902A1Umbilical cord amniotic membrane productsTISSUETECH INC·Filed 2016·Application pending·0 cites
- 3358US2015203814A1Methods of isolating and culturing stem cellsTISSUETECH INC·Filed 2014·Application pending·0 cites
- 3458US2016184368A1Umbilical cord amniotic membrane productsTISSUETECH INC·Filed 2016·Application pending·0 cites
- 3557US2016106785A1Umbilical cord productsTISSUETECH INC·Filed 2015·Application pending·0 cites
- 3654US2007128719A1Isolation and expansion of animal cells in cell culturesTISSUETECH INC·Filed 2006·Application pending·0 cites
- 3754US2007010008A1Ex vivo expansion of primary animal cellsTISSUETECH INC·Filed 2006·Application pending·0 cites
- 3854US2023083005A1Methods of killing or inhibiting the growth of cancer cellsTISSUETECH INC·Filed 2021·Application pending·0 cites
- 3953US2024000704A1Methods of using umbilical cord products for treatment of ocular surface disordersTISSUETECH INC·Filed 2021·Application pending·0 cites
- 4053US2021386791A1Methods of cellular reprogrammingTISSUETECH INC·Filed 2019·Application pending·0 cites
- 4149US2016243288A1Apparatuses and methods for treating ophthalmic diseases and disordersTISSUETECH INC·Filed 2016·Application pending·0 cites
- 4248US2023172994A1Methods of promoting vasculogenesisTISSUETECH INC·Filed 2020·Application pending·0 cites
- 4344US2014106448A1Methods of isolating cellsTISSUETECH INC·Filed 2012·Application pending·0 cites
- 4443US2016095931A1Compositions containing hc-ha complex and methods of use thereofTISSUETECH INC·Filed 2015·Application pending·0 cites
- 4542US2016120912A1Compositions and method for promoting nerve growth and regenerationTISSUETECH INC·Filed 2015·Application pending·0 cites
- 4639US2016008295A1Compositions and methods for treating rosaceaTISSUETECH INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TISSUETECH INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →